Fda grants nutriband meeting request for aversa™ fentanyl abuse deterrent fentanyl patch

Fda grants meeting for aversa™ fentanyl (abuse deterrent transdermal system) to provide feedback on the chemistry, manufacturing, and controls plans for the product through commercialization. nutriband is partnering with kindeva to develop aversa™ fentanyl which combines nutriband's aversa™ abuse-deterrent technology with kindeva's fda-approved fentanyl patch.

NTRB Ratings Summary

NTRB Quant Ranking